| MeSH term | MeSH ID | Detail |
|---|---|---|
| Melanoma | D008545 | 69 associated lipids |
| Anemia, Aplastic | D000741 | 6 associated lipids |
| Asthma | D001249 | 52 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Chemical and Drug Induced Liver Injury | D056486 | 39 associated lipids |
| Liver Neoplasms, Experimental | D008114 | 46 associated lipids |
| Proteinuria | D011507 | 30 associated lipids |
| Thyroid Neoplasms | D013964 | 33 associated lipids |
Sphingosine 1-phosphate
Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
Cross Reference
Introduction
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Sphingosine 1-phosphate?
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
PubChem Associated disorders and diseases
What pathways are associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Sphingosine 1-phosphate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Sphingosine 1-phosphate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Sphingosine 1-phosphate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Sphingosine 1-phosphate?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Sphingosine 1-phosphate?
Knock-out
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Sphingosine 1-phosphate
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Itoh R et al. | Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells. | 2010 | J. Bone Miner. Metab. | pmid:20458606 |
| Bankovich AJ et al. | CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. | 2010 | J. Biol. Chem. | pmid:20463015 |
| Gorbunova E et al. | Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. | 2010 | J. Virol. | pmid:20463083 |
| Liu Z et al. | Mechanical tugging force regulates the size of cell-cell junctions. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20463286 |
| Müller R et al. | Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells. | 2010 | Tumour Biol. | pmid:20480410 |
| Maeda Y et al. | Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow. | 2010 | Int. Immunol. | pmid:20497959 |
| Prakash H et al. | Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages. | 2010 | PLoS ONE | pmid:20498849 |
| Bergelin N et al. | S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration. | 2010 | Endocrinology | pmid:20501673 |
| Gräler MH | Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions. | 2010 | Cell. Physiol. Biochem. | pmid:20502007 |
| Lucke S and Levkau B | Endothelial functions of sphingosine-1-phosphate. | 2010 | Cell. Physiol. Biochem. | pmid:20502008 |
| Dubin AE et al. | Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis. | 2010 | J. Neurosci. | pmid:20505096 |
| Zhang H et al. | Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. | 1991 | J. Cell Biol. | pmid:2050740 |
| Zhou Y et al. | Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway. | 2010 | Stroke | pmid:20508187 |
| Long JS et al. | Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells. | 2010 | Mol. Cell. Biol. | pmid:20516217 |
| De Luca T et al. | Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells. | 2010 | J. Cell. Biochem. | pmid:20518072 |
| Seo YJ et al. | Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. | 2010 | J. Virol. | pmid:20519401 |
| Lee MH et al. | HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate. | 2010 | J. Lipid Res. | pmid:20522601 |
| Pchejetski D et al. | Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer. | 2010 | Breast Cancer Res. Treat. | pmid:20535545 |
| Kamradt T and Frey O | Arthritis: where are the T cells? | 2010 | Arthritis Res. Ther. | pmid:20537200 |
| Esche M et al. | Signalling of sphingosine-1-phosphate in Müller glial cells via the S1P/EDG-family of G-protein-coupled receptors. | 2010 | Neurosci. Lett. | pmid:20540988 |
| Adamson RH et al. | Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. | 2010 | Cardiovasc. Res. | pmid:20542878 |
| Wirrig C et al. | Sphingosylphosphorylcholine is a proinflammatory mediator in cerebral arteries. | 2011 | J. Cereb. Blood Flow Metab. | pmid:20551970 |
| Chiba Y et al. | Downregulation of sphingosine-1-phosphate receptors in bronchial smooth muscle of mouse experimental asthma. | 2010 | Pharmacol. Res. | pmid:20554039 |
| Murohara T | Printing a tissue: a new engineering strategy for cardiovascular regeneration. | 2010 | Arterioscler. Thromb. Vasc. Biol. | pmid:20554948 |
| Pyne NJ and Pyne S | Sphingosine 1-phosphate and cancer. | 2010 | Nat. Rev. Cancer | pmid:20555359 |
| Fyrst H and Saba JD | An update on sphingosine-1-phosphate and other sphingolipid mediators. | 2010 | Nat. Chem. Biol. | pmid:20559316 |
| Valentine WJ et al. | (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity. | 2010 | Cell. Signal. | pmid:20566326 |
| Blachnio-Zabielska A et al. | Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle. | 2010 | J. Cell. Physiol. | pmid:20568228 |
| Blom T et al. | An autocrine sphingosine-1-phosphate signaling loop enhances NF-kappaB-activation and survival. | 2010 | BMC Cell Biol. | pmid:20573281 |
| Alvarez SE et al. | Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. | 2010 | Nature | pmid:20577214 |
| He X et al. | Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human adult bone marrow and adipose tissue-derived stem cells. | 2010 | J Mol Cell Biol | pmid:20584786 |
| Thangada S et al. | Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. | 2010 | J. Exp. Med. | pmid:20584883 |
| Kilbey A et al. | Runx regulation of sphingolipid metabolism and survival signaling. | 2010 | Cancer Res. | pmid:20587518 |
| Sumida GM and Stamer WD | Sphingosine-1-phosphate enhancement of cortical actomyosin organization in cultured human Schlemm's canal endothelial cell monolayers. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:20592229 |
| Maiese K | Choices and outcomes: Extending basic biology to clinical care. | 2009 Jul-Aug | Oxid Med Cell Longev | pmid:20592765 |
| Vessey DA et al. | Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning. | 2009 Jul-Aug | Oxid Med Cell Longev | pmid:20592769 |
| Cusack KP and Stoffel RH | S1P(1) receptor agonists: Assessment of selectivity and current clinical activity. | 2010 | Curr Opin Drug Discov Devel | pmid:20597031 |
| Zabielski P et al. | The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20599517 |
| Cutignano A et al. | UPLC-MS/MS method for analysis of sphingosine 1-phosphate in biological samples. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20601074 |
| Meacci E et al. | Functional interaction between TRPC1 channel and connexin-43 protein: a novel pathway underlying S1P action on skeletal myogenesis. | 2010 | Cell. Mol. Life Sci. | pmid:20614160 |
| Ohno T et al. | The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling. | 2010 | Biopharm Drug Dispos | pmid:20623701 |
| Gurgui M et al. | Dual action of sphingosine 1-phosphate in eliciting proinflammatory responses in primary cultured rat intestinal smooth muscle cells. | 2010 | Cell. Signal. | pmid:20624458 |
| Rosa JM et al. | Permissive role of sphingosine on calcium-dependent endocytosis in chromaffin cells. | 2010 | Pflugers Arch. | pmid:20640579 |
| Baker DA et al. | Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. | 2010 | J. Immunol. | pmid:20644167 |
| Lan T et al. | Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway. | 2010 | Arch. Biochem. Biophys. | pmid:20646989 |
| Seo J et al. | Sphingosine-1-phosphate signaling in human submandibular cells. | 2010 | J. Dent. Res. | pmid:20651091 |
| Sattler KJ et al. | Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. | 2010 | Basic Res. Cardiol. | pmid:20652276 |
| Weis T et al. | Sphingosine 1-phosphate (S1P) induces expression of E-selectin and adhesion of monocytes via intracellular signalling pathways in vascular endothelial cells. | 2010 | Eur. J. Cell Biol. | pmid:20656374 |
| Hoefer J et al. | Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction. | 2010 | Circ. Res. | pmid:20671234 |
| Tengood JE et al. | Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. | 2010 | Biomaterials | pmid:20674008 |
| Jee BC et al. | Effect of sphingosine-1-phosphate supplementation on follicular integrity of vitrified-warmed mouse ovarian grafts. | 2010 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:20674140 |
| Canals D et al. | Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane. | 2010 | J. Biol. Chem. | pmid:20679347 |
| Chumanevich AA et al. | Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. | 2010 | Carcinogenesis | pmid:20688834 |
| Morris MA et al. | Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells. | 2011 | Autoimmunity | pmid:20695767 |
| Bourquin F et al. | Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism. | 2010 | Structure | pmid:20696404 |
| Kim MG et al. | CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. | 2011 | Nephrol. Dial. Transplant. | pmid:20702533 |
| Medlin MD et al. | Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation. | 2010 | Arterioscler. Thromb. Vasc. Biol. | pmid:20702813 |
| Samadi N et al. | Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. | 2011 | Biochimie | pmid:20709140 |
| Nishimura B et al. | The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea. | 2010 | Neurosci. Lett. | pmid:20709153 |
| Swan DJ et al. | Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation. | 2010 | J. Cell. Mol. Med. | pmid:20716131 |
| Mair KM et al. | Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery. | 2010 | Br. J. Pharmacol. | pmid:20718749 |
| Nelson CJ et al. | Global analysis of circulating metabolites in hibernating ground squirrels. | 2010 | Comp. Biochem. Physiol. Part D Genomics Proteomics | pmid:20728417 |
| Zhang G et al. | Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules. | 2010 | Am. J. Physiol. Heart Circ. Physiol. | pmid:20729401 |
| Im DS | Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors. | 2010 | Acta Pharmacol. Sin. | pmid:20729877 |
| Wuertz CM et al. | p63RhoGEF--a key mediator of angiotensin II-dependent signaling and processes in vascular smooth muscle cells. | 2010 | FASEB J. | pmid:20739613 |
| Lépine S et al. | Sphingosine-1-phosphate phosphohydrolase-1 regulates ER stress-induced autophagy. | 2011 | Cell Death Differ. | pmid:20798685 |
| Berdyshev EV et al. | Characterization of sphingosine-1-phosphate lyase activity by electrospray ionization-liquid chromatography/tandem mass spectrometry quantitation of (2E)-hexadecenal. | 2011 | Anal. Biochem. | pmid:20804717 |
| Pattanaik D and Postlethwaite AE | A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis. | 2010 | Discov Med | pmid:20807477 |
| Bucki R et al. | Plasma gelsolin modulates cellular response to sphingosine 1-phosphate. | 2010 | Am. J. Physiol., Cell Physiol. | pmid:20810916 |
| Bäumer W et al. | Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. | 2011 | J. Invest. Dermatol. | pmid:20811395 |
| Jiang Z et al. | Metabonomic study on women of reproductive age treated with nutritional intervention: screening potential biomarkers related to neural tube defects occurrence. | 2011 | Biomed. Chromatogr. | pmid:20812204 |
| Yonesu K et al. | A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate. | 2010 | Biol. Pharm. Bull. | pmid:20823564 |
| Durafourt BA et al. | Differential responses of human microglia and blood-derived myeloid cells to FTY720. | 2011 | J. Neuroimmunol. | pmid:20826007 |
| Long JS et al. | Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. | 2010 | J. Biol. Chem. | pmid:20837468 |
| Deshpande GP et al. | Effects of sphingosine-1-phosphate on acute contractile heart failure (ACHF). | 2010 | Cardiovasc Drugs Ther | pmid:20838867 |
| Chi XX and Nicol GD | The sphingosine 1-phosphate receptor, S1PRâ‚, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons. | 2010 | J. Neurophysiol. | pmid:20844107 |
| Liu G et al. | The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. | 2010 | Nat. Immunol. | pmid:20852647 |
| Gil PR et al. | Sphingosine 1-phosphate mediates chemotaxis of human primary fibroblasts via the S1P-receptor subtypes S1P₠and S1P₃ and Smad-signalling. | 2010 | Cytoskeleton (Hoboken) | pmid:20857421 |
| Dudek SM et al. | Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. | 2010 | Mol. Biol. Cell | pmid:20861316 |
| Komatsu I et al. | Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II. | 2010 | J Hand Surg Am | pmid:20888494 |
| Watson C et al. | High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. | 2010 | Am. J. Pathol. | pmid:20889557 |
| Strub GM et al. | Extracellular and intracellular actions of sphingosine-1-phosphate. | 2010 | Adv. Exp. Med. Biol. | pmid:20919652 |
| Oskouian B and Saba JD | Cancer treatment strategies targeting sphingolipid metabolism. | 2010 | Adv. Exp. Med. Biol. | pmid:20919655 |
| Scherer EQ et al. | Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. | 2010 | Stroke | pmid:20930159 |
| Zhang N et al. | FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. | 2010 | Autophagy | pmid:20935520 |
| Greenspon J et al. | Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function. | 2011 | Dig. Dis. Sci. | pmid:20936358 |
| Kelly RF et al. | Ethanolamine is a novel STAT-3 dependent cardioprotective agent. | 2010 | Basic Res. Cardiol. | pmid:20938668 |
| Su SC et al. | Annexin 2 regulates endothelial morphogenesis by controlling AKT activation and junctional integrity. | 2010 | J. Biol. Chem. | pmid:20947498 |
| Chiba Y et al. | SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice. | 2010 | J. Pharmacol. Sci. | pmid:20948165 |
| Barra V et al. | Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB. | 2011 | Cell. Mol. Life Sci. | pmid:20949368 |
| Kanno T et al. | Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus. | 2010 | Neuroscience | pmid:20950672 |
| Browne CD et al. | SHEP1 partners with CasL to promote marginal zone B-cell maturation. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20956287 |
| Strub GM et al. | Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. | 2011 | FASEB J. | pmid:20959514 |
| Wang F et al. | Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. | 2010 | J. Clin. Invest. | pmid:20978351 |
| Sekine Y et al. | HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion. | 2011 | Prostate | pmid:20979115 |
| Noguchi K and Chun J | Roles for lysophospholipid S1P receptors in multiple sclerosis. | 2011 | Crit. Rev. Biochem. Mol. Biol. | pmid:20979571 |
| Becker S et al. | Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1. | 2011 | Biol. Reprod. | pmid:20980685 |
| Józefowski S et al. | Ceramide and ceramide 1-phosphate are negative regulators of TNF-α production induced by lipopolysaccharide. | 2010 | J. Immunol. | pmid:21041721 |
| Xia P and Wadham C | Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling. | 2011 | Cytokine Growth Factor Rev. | pmid:21051273 |
| Lee CW et al. | Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis. | 2010 | Arch. Pharm. Res. | pmid:21052934 |